Created through research funded by the UK’s Wellcome Trust, the new artificial blood was created using human stem cells. Through the use of induced pluripotent stem cells (iPS), researchers were able to subject the impressionable tissues to conditions similar to those found in the human body. After this rigorous culturing process the iPS cells matured into red blood cells – specifically the universal donor Type-O blood cells.
“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Professor Marc Turner.
According to researchers, the first clinical trials involving the new artificial blood will begin in late 2016 or early 2017. If researchers can successfully negotiate these trials it could very well become a cornerstone of medical science. What’s more, if researchers can tweak their production method to produce blood on an industrial scale thousands of patients suffering from curable conditions may finally have access to a technology that can save their lives. Who knows, maybe this technology could be the breakthrough that enables the development of critical medical infrastructure and practices in the most remote corners of the planet.
Image Courtesy of andrejanel